Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 134Breast Neoplasms 91Neoplasms 8Breast Neoplasms, Male 6Neoplasm Metastasis 5Advanced Breast Cancer 4Salivary Gland Neoplasms 3Prostate Adenocarcinoma 3Triple Negative Breast Neoplasms 2Recurrence 2Osteoporosis 2Leiomyoma 2Infertility 2Advanced Prostate Cancer 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Radiation Injuries 1Primary Ovarian Insufficiency 1Primary Dysautonomias 1Patients With T1-4 Advanced Prostate Cancer 1PSA Level Greater Than Two 1Ovarian Neoplasms 1Osteitis Deformans 1Myofibroma 1Lymphatic Metastasis 1Kidney Diseases 1Inflammatory Breast Neoplasms 1Hypertension 1Hyperlipidemias 1

Interventions

Goserelin 2enzalutamide 1bicalutamide 1Radiosurgery 1Leuprolide 1Docetaxel 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Advanced Prostate Cancer × Goserelin × Clear all
NCT03936218 2025-04-17

Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

Eurofarma Laboratorios S.A.

Phase 3 Completed
94 enrolled
Genitourinary

Advanced Prostate Cancer

NCT03971110 2022-12-16

A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

AstraZeneca

Phase 4 Terminated
9 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡